Activation of the human insulin receptor by non-insulin-related peptides.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
28 09 2022
Historique:
received: 21 04 2022
accepted: 12 09 2022
entrez: 28 9 2022
pubmed: 29 9 2022
medline: 1 10 2022
Statut: epublish

Résumé

The human insulin receptor signalling system plays a critical role in glucose homeostasis. Insulin binding brings about extensive conformational change in the receptor extracellular region that in turn effects trans-activation of the intracellular tyrosine kinase domains and downstream signalling. Of particular therapeutic interest is whether insulin receptor signalling can be replicated by molecules other than insulin. Here, we present single-particle cryoEM structures that show how a 33-mer polypeptide unrelated to insulin can cross-link two sites on the receptor surface and direct the receptor into a signalling-active conformation. The 33-mer polypeptide engages the receptor by two helical binding motifs that are each potentially mimicable by small molecules. The resultant conformation of the receptor is distinct from-but related to-those in extant three-dimensional structures of the insulin-complexed receptor. Our findings thus illuminate unexplored pathways for controlling the signalling of the insulin receptor as well as opportunities for development of insulin mimetics.

Identifiants

pubmed: 36171189
doi: 10.1038/s41467-022-33315-8
pii: 10.1038/s41467-022-33315-8
pmc: PMC9519552
doi:

Substances chimiques

Insulin 0
Receptor, Insulin EC 2.7.10.1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5695

Informations de copyright

© 2022. The Author(s).

Références

Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
J Biol Chem. 2002 Jun 21;277(25):22590-4
pubmed: 11964401
J Biol Chem. 2016 Jul 22;291(30):15473-81
pubmed: 27281820
Nature. 2001 Dec 13;414(6865):799-806
pubmed: 11742412
Proteins. 2008 Apr;71(1):426-39
pubmed: 17957771
Science. 1991 Oct 25;254(5031):539-44
pubmed: 1948029
Biochem Biophys Res Commun. 2008 Nov 14;376(2):380-3
pubmed: 18782558
FEBS J. 2022 May;289(9):2657-2671
pubmed: 34826178
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):531-544
pubmed: 29872004
Biochemistry. 2009 Jun 16;48(23):5492-500
pubmed: 19459609
J Biol Chem. 1997 Nov 21;272(47):29460-7
pubmed: 9368005
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Acta Crystallogr D Struct Biol. 2021 Apr 1;77(Pt 4):438-446
pubmed: 33825704
J Mol Biol. 2022 Mar 15;434(5):167458
pubmed: 35074483
Nature. 2010 Sep 2;467(7311):52-8
pubmed: 20811451
Nature. 2006 Sep 14;443(7108):218-21
pubmed: 16957736
Elife. 2019 Aug 22;8:
pubmed: 31436533
Nat Rev Drug Discov. 2002 Oct;1(10):769-83
pubmed: 12360255
Structure. 2016 Mar 1;24(3):469-76
pubmed: 26853939
Elife. 2014 Sep 25;3:
pubmed: 25255214
J Biol Chem. 1988 Aug 25;263(24):11768-75
pubmed: 2457026
Structure. 2018 May 1;26(5):759-766.e4
pubmed: 29706530
BMC Res Notes. 2012 Jul 23;5:367
pubmed: 22824207
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874
pubmed: 30768902
Biochem Biophys Res Commun. 1989 Feb 28;159(1):312-6
pubmed: 2538124
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Biochem J. 1986 Apr 1;235(1):199-208
pubmed: 2427071
Biochem J. 2000 May 1;347 Pt 3:771-9
pubmed: 10769182
Nature. 2018 Apr 5;556(7699):122-125
pubmed: 29512653
Mol Cell Biol. 1985 Dec;5(12):3610-6
pubmed: 3915782
Protein Sci. 1997 Dec;6(12):2663-6
pubmed: 9416620
Elife. 2018 Nov 09;7:
pubmed: 30412051
Nat Commun. 2018 Oct 24;9(1):4420
pubmed: 30356040
Biochem J. 2021 Dec 22;478(24):4169-4185
pubmed: 34783343
Proteins. 2006 Nov 15;65(3):712-25
pubmed: 16981200
Commun Biol. 2019 Jun 19;2:218
pubmed: 31240256
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Cell. 1985 Apr;40(4):747-58
pubmed: 2859121
J Cell Biol. 2020 Jan 6;219(1):
pubmed: 31727777
FEBS Lett. 2000 Aug 11;479(1-2):15-8
pubmed: 10940380
Mol Metab. 2021 Oct;52:101255
pubmed: 33992784
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4435-9
pubmed: 12684539
Biochem Biophys Res Commun. 1973 Nov 1;55(1):154-61
pubmed: 4361269
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774

Auteurs

Nicholas S Kirk (NS)

WEHI, 1G Royal Parade, Parkville, VIC, 3052, Australia.
Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3050, Australia.

Qi Chen (Q)

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.

Yingzhe Ginger Wu (YG)

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.

Anastasia L Asante (AL)

Advanced Testing Laboratories, Blue Ash, OH, 45242, USA.

Haitao Hu (H)

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.

Juan F Espinosa (JF)

Centro de Investigación Lilly S.A., Avda. de la Industria 30, Alcobendas, Madrid, 28108, Spain.

Francisco Martínez-Olid (F)

Centro de Investigación Lilly S.A., Avda. de la Industria 30, Alcobendas, Madrid, 28108, Spain.

Mai B Margetts (MB)

WEHI, 1G Royal Parade, Parkville, VIC, 3052, Australia.

Faiz A Mohammed (FA)

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.

Vladislav V Kiselyov (VV)

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. kiselyov_vladislav@lilly.com.

David G Barrett (DG)

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. david.barrett@beigene.com.

Michael C Lawrence (MC)

WEHI, 1G Royal Parade, Parkville, VIC, 3052, Australia. lawrence@wehi.edu.au.
Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3050, Australia. lawrence@wehi.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH